Regenerative medicine, such as stem cell therapy, is the development and application of new treatments to replace or regenerate human tissue, cells or organs to establish normal function. As technology advancement continues to grow each year, so does the usage of these techniques. For example, 3D printing has created a new direction in biomanufacturing for tissue engineering. There are currently more than 1,500 regenerative medicine clinical trials in GlobalData’s Pharma Intelligence Centre, with this number rising every year.

Overall, the number of regenerative medicine clinical trials increased from 2005 to 2018, with the most in 2020 at 10.1% of trials (Figure 1). 2020 was a key year for this practice due to several factors. According to the Alliance for Regenerative Medicine’s (ARM) 2020 annual report, these factors included the highest funding year, which raised a record $19.9bn, and an increase of 100 regenerative medicine developers from the previous year.

Two new therapies were also approved in 2020: Orchard Therapeutics’ Libmeldy, a gene therapy for the treatment of metachromatic leukodystrophy, received approval from the European Medicines Agency (EMA), while Kite’s Tecartus, the first CAR-T for the treatment of relapsed or refractory B-cell acute lymphoblastic leukaemia, received US Food and Drug Administration (FDA) approval.

The increasing number of regenerative medicine trials annually and the greater number of therapeutic drug approvals suggest that the practice will continue to be key in future drug development.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.